Showing results (241-250 of 604) with videos related to

Sort By:
Pageof 61
Rheumatology (Oxford, England)|July 1, 2004
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade)G Kobelt, P Andlin-Sobocki, S Brophy, et al.
Frontiers in Oncology|November 5, 2019
Long Non-coding RNAs in Myeloid MalignanciesAlina-Andreea Zimta, Ciprian Tomuleasa, Iman Sahnoune, et al.
Molecular Aspects of Medicine|August 14, 2018
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevanceMohammad Askandar Iqbal, Shweta Arora, Gopinath Prakasam, et al.
The Journal of Rheumatology|November 1, 1981
Reiter's syndrome following epidemic shigellosisD G Simon, R A Kaslow, J Rosenbaum, et al.
Rheumatology (Oxford, England)|October 9, 1999
Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?A Calin, J P Nakache, A Gueguen, et al.
Arthritis and Rheumatism|June 17, 2000
The X-chromosome and susceptibility to ankylosing spondylitisE Hoyle, S H Laval, A Calin, et al.
The Journal of Rheumatology|December 1, 1994
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity IndexS Garrett, T Jenkinson, L G Kennedy, et al.
The Journal of Rheumatology|April 1, 1997
Juvenile onset ankylosing spondylitis--more girls than we thought?K S Gomez, K Raza, S D Jones, et al.
The Journal of Rheumatology|March 1, 1996
Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factorsS D Jones, W H Koh, A Steiner, et al.
Cancers|July 26, 2020
MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization MethodsRares Drula, Leonie Florence Ott, Ioana Berindan-Neagoe, et al.
Pageof 61